Peripheral neuropathy decisions — 2025

The Board granted service connection for diabetes mellitus, type II, left and right lower extremity peripheral neuropathy, and hypertension, all presumed to be due to herbicide exposure during the Veteran's service in Korea.

The Board remands the claims for service connection for an acquired psychiatric disorder, peripheral neuropathy of the upper and lower extremities, and chronic kidney disease to correct pre-decisional duty to assist errors.

The Board remands the claim for an initial compensable evaluation for right residual ilioinguinal nerve paresthesia to ensure the Veteran is informed of his right to request a pre-decisional hearing.

The Board granted a 10 percent rating for hypocomplementemic urticarial vasculitis (HUV) from June 16, 2022, and service connection for left lower extremity peripheral neuropathy but denied it for the right lower extremity.

The Board granted an earlier effective date of September 19, 2023 for the grants of service connection for tinnitus and bilateral hearing loss. The claims for other conditions were remanded for further development.

The Veteran is granted a total disability rating based on individual unemployability (TDIU) due to his service-connected diabetes mellitus, type II, and its complications effective February 19, 2024, as well as special monthly compensation at the housebound rate for the same date.

The Board granted service connection for right lower extremity peripheral neuropathy, finding it to be secondary to the Veteran's service-connected diabetes mellitus.

The Board remands multiple issues related to the Veteran's service-connected conditions for further development and adjudication.

The Board denied service connection for mantle cell lymphoma, emphysema, diabetes mellitus, Type II, bilateral foot neuropathy, and an acquired psychiatric disorder, including PTSD and antisocial personality disorder.

The Board granted increased initial ratings of 60 percent for sensorimotor peripheral neuropathy of both lower extremities, as well as service connection and a TDIU.

The Board dismissed all issues as a matter of law due to a procedural defect in the Veteran's February 2023 VA Form 10182s, which attempted to concurrently elect multiple review options.

The Board remands the claims for service connection for ulnar neuropathy of both upper extremities due to an inadequate VA examination.

The Veteran has withdrawn the appeal for service connection for colon cancer with metastatic liver and lymphatic cancer, and bilateral lower extremity peripheral neuropathy.

The Board granted service connection for pancreatic cancer with cholangitis under the PACT Act, and for right and left upper and lower extremity neuropathy as secondary to pancreatic cancer. The claims for a headache disability and obstructive sleep apnea were denied.

The Board granted service connection for a skin disorder, to include boils and skin lesions as due to herbicide agent exposure, and peripheral neuropathy in all four extremities as due to herbicide agent exposure.

The Board granted service connection for a back disability and bilateral lower extremity peripheral neuropathy, both related to in-service herbicide exposure. The IBS claim was remanded.

The Board granted service connection for a back condition but denied service connection for bilateral upper extremity neuropathy and a skin condition of the feet and ankles.

The Board denied service connection for a disability claimed as depleted uranium and remanded the claims for peripheral neuropathy, diabetes mellitus, an eye disorder, a prostate disorder, and a gastrointestinal disorder.

The Board denied the appellant's claims for an earlier effective date for service connection for various conditions related to Parkinson's Disease, as these conditions arose after the passage of the PACT Act on August 10, 2022.

The Board remands the Veteran's claims for a higher disability rating for left and right lower sciatic peripheral neuropathy due to an incomplete evaluation of the severity of his condition without considering medication effects.